Literature DB >> 31285370

BAP1 Loss Is Associated with DNA Methylomic Repatterning in Highly Aggressive Class 2 Uveal Melanomas.

Matthew G Field1, Jeffim N Kuznetsov1, Parker L Bussies1, Louie Z Cai1, Karam A Alawa1, Christina L Decatur1, Stefan Kurtenbach1, J William Harbour2.   

Abstract

PURPOSE: The strong association between BAP1 mutations and metastasizing Class 2 uveal melanoma (UM) suggests that epigenetic alterations may play a significant role in tumor progression. Thus, we characterized the impact of BAP1 loss on the DNA methylome in UM.Experimental Design: Global DNA methylation was analyzed in 47 Class 1 and 45 Class 2 primary UMs and in UM cells engineered to inducibly deplete BAP1. RNA-Seq was analyzed in 80 UM samples and engineered UM cells.
RESULTS: Hypermethylation on chromosome 3 correlated with downregulated gene expression at several loci, including 3p21, where BAP1 is located. Gene set analysis of hypermethylated and downregulated genes identified axon guidance and melanogenesis as deregulated pathways, with several of these genes located on chromosome 3. A novel hypermethylated site within the BAP1 locus was found in all Class 2 tumors, suggesting that BAP1 itself is epigenetically regulated. Highly differentially methylated probes were orthogonally validated using bisulfite sequencing, and they successfully distinguished Class 1 and Class 2 tumors in 100% of cases. In functional validation experiments, BAP1 knockdown in UM cells induced methylomic repatterning similar to UM tumors, enriched for genes involved in axon guidance, melanogenesis, and development.
CONCLUSIONS: This study, coupled with previous work, suggests that the initial event in the divergence of Class 2 UM from Class 1 UM is loss of one copy of chromosome 3, followed by mutation of BAP1 on the remaining copy of chromosome 3, leading to the methylomic repatterning profile characteristic of Class 2 UMs. ©2019 American Association for Cancer Research.

Entities:  

Year:  2019        PMID: 31285370      PMCID: PMC6744995          DOI: 10.1158/1078-0432.CCR-19-0366

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  56 in total

Review 1.  Mitf from neural crest to melanoma: signal transduction and transcription in the melanocyte lineage.

Authors:  C R Goding
Journal:  Genes Dev       Date:  2000-07-15       Impact factor: 11.361

2.  Tcf3 and Lef1 regulate lineage differentiation of multipotent stem cells in skin.

Authors:  B J Merrill; U Gat; R DasGupta; E Fuchs
Journal:  Genes Dev       Date:  2001-07-01       Impact factor: 11.361

Review 3.  Microphthalamia-associated transcription factor: a critical regulator of pigment cell development and survival.

Authors:  Hans R Widlund; David E Fisher
Journal:  Oncogene       Date:  2003-05-19       Impact factor: 9.867

4.  Identification of patterns in biological sequences at the ALGGEN server: PROMO and MALGEN.

Authors:  Domènec Farré; Romà Roset; Mario Huerta; José E Adsuara; Llorenç Roselló; M Mar Albà; Xavier Messeguer
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

5.  Multiple locations on chromosome 3 are the targets of specific deletions in uveal melanoma.

Authors:  N A Cross; A Ganesh; M Parpia; A K Murray; I G Rennie; K Sisley
Journal:  Eye (Lond)       Date:  2006-04       Impact factor: 3.775

6.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

7.  Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death.

Authors:  Michael D Onken; Lori A Worley; Justis P Ehlers; J William Harbour
Journal:  Cancer Res       Date:  2004-10-15       Impact factor: 12.701

8.  Lentivirus-delivered stable gene silencing by RNAi in primary cells.

Authors:  Sheila A Stewart; Derek M Dykxhoorn; Deborah Palliser; Hana Mizuno; Evan Y Yu; Dong Sung An; David M Sabatini; Irvin S Y Chen; William C Hahn; Phillip A Sharp; Robert A Weinberg; Carl D Novina
Journal:  RNA       Date:  2003-04       Impact factor: 4.942

9.  Tumor classification based on gene expression profiling shows that uveal melanomas with and without monosomy 3 represent two distinct entities.

Authors:  Frank Tschentscher; Johannes Hüsing; Tanja Hölter; Elisabeth Kruse; Irina Gana Dresen; Karl-Heinz Jöckel; Gerasimos Anastassiou; Harald Schilling; Norbert Bornfeld; Bernhard Horsthemke; Dietmar Rudolf Lohmann; Michael Zeschnigk
Journal:  Cancer Res       Date:  2003-05-15       Impact factor: 12.701

10.  The endothelin receptor-B is required for the migration of neural crest-derived melanocyte and enteric neuron precursors.

Authors:  Hyung-Ok Lee; John M Levorse; Myung K Shin
Journal:  Dev Biol       Date:  2003-07-01       Impact factor: 3.582

View more
  16 in total

1.  Loss of BAP1 in Pheochromocytomas and Paragangliomas Seems Unrelated to Genetic Mutations.

Authors:  Valeria Maffeis; Rocco Cappellesso; Lorenzo Nicolè; Vincenza Guzzardo; Chiara Menin; Lisa Elefanti; Francesca Schiavi; Maria Guido; Ambrogio Fassina
Journal:  Endocr Pathol       Date:  2019-12       Impact factor: 3.943

2.  NSUN2-mediated RNA m5C modification modulates uveal melanoma cell proliferation and migration.

Authors:  Guangying Luo; Weiwei Xu; Xiaoyan Chen; Siqi Wang; Jiao Wang; Feng Dong; Dan-Ning Hu; Peter S Reinach; Dongsheng Yan
Journal:  Epigenetics       Date:  2022-06-26       Impact factor: 4.861

Review 3.  Ubiquitin-proteasome system-targeted therapy for uveal melanoma: what is the evidence?

Authors:  Chen-Xi Zhao; Chen-Ming Zeng; Ke Wang; Qiao-Jun He; Bo Yang; Fan-Fan Zhou; Hong Zhu
Journal:  Acta Pharmacol Sin       Date:  2020-06-29       Impact factor: 6.150

Review 4.  Roles of the BAP1 Tumor Suppressor in Cell Metabolism.

Authors:  Anna Han; Timothy J Purwin; Andrew E Aplin
Journal:  Cancer Res       Date:  2021-01-14       Impact factor: 13.312

Review 5.  Clinicopathological and prognostic significance and molecular mechanisms governing uveal melanoma.

Authors:  Meng-Yu Wu; Tzu-Ting Lai; Wan-Ting Liao; Chia-Jung Li
Journal:  Ther Adv Med Oncol       Date:  2020-06-08       Impact factor: 8.168

6.  Verification of EZH2 as a druggable target in metastatic uveal melanoma.

Authors:  Bei Jin; Ping Zhang; Hailin Zou; Huijing Ye; Yun Wang; Jing Zhang; Huasheng Yang; Jingxuan Pan
Journal:  Mol Cancer       Date:  2020-03-04       Impact factor: 27.401

Review 7.  Targeting Epigenetic Modifications in Uveal Melanoma.

Authors:  Pooneh Chokhachi Baradaran; Zuzana Kozovska; Alena Furdova; Bozena Smolkova
Journal:  Int J Mol Sci       Date:  2020-07-27       Impact factor: 5.923

8.  Current molecular and clinical insights into uveal melanoma (Review).

Authors:  Matteo Fallico; Giuseppina Raciti; Antonio Longo; Michele Reibaldi; Vincenza Bonfiglio; Andrea Russo; Rosario Caltabiano; Giuseppe Gattuso; Luca Falzone; Teresio Avitabile
Journal:  Int J Oncol       Date:  2021-03-02       Impact factor: 5.650

Review 9.  Melanoma pathology: new approaches and classification.

Authors:  I Yeh; B C Bastian
Journal:  Br J Dermatol       Date:  2021-05-31       Impact factor: 11.113

Review 10.  The "ART" of Epigenetics in Melanoma: From histone "Alterations, to Resistance and Therapies".

Authors:  Thomas Strub; Robert Ballotti; Corine Bertolotto
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.